Quarterly ResultMay 14, 2026, 07:16 AM
Cellebrite Q1 Revenue $128.3M, +19%; ARR $493M, +21%; EPS $0.12
AI Summary
Cellebrite DI Ltd. announced strong first-quarter 2026 financial results, with revenue increasing 19% year-over-year to $128.3 million and Annual Recurring Revenue (ARR) growing 21% to $493.0 million. The company also reported non-GAAP diluted EPS of $0.12 and non-GAAP net income of $30.6 million. Key business highlights included the acquisition of SCG Canada Inc. to expand into drone forensics, the introduction of new AI-powered solutions like Cellebrite Genesis and Guardian Investigate, and achieving FedRAMP® High Authorization for its Government Cloud platform. Cellebrite provided an optimistic outlook, projecting Q2 2026 ARR of $510 million to $513 million and full-year 2026 revenue of $565 million to $571 million.
Key Highlights
- Q1 2026 Revenue was $128.3 million, up 19% year-over-year.
- Total Annual Recurring Revenue (ARR) reached $493.0 million, a 21% increase year-over-year.
- Non-GAAP diluted earnings per share (EPS) for Q1 2026 was $0.12.
- Non-GAAP net income for Q1 2026 was $30.6 million.
- Cellebrite closed the acquisition of SCG Canada Inc. on March 1, 2026, adding drone forensics.
- Introduced early access to Cellebrite Genesis (agentic AI) and general availability of Guardian Investigate.
- Q2 2026 ARR outlook is $510 million to $513 million, representing 22%-23% annual growth.
- Full-Year 2026 revenue outlook is $565 million to $571 million, representing 19%-20% annual growth.